Christian ChavyLuck factor —Luck data is unavailable for this scope.

Follow this person across linked issuers and source filings.

PersonFR · AMFFrance public disclosures

Companies in disclosed relationships

Public filings

Net disclosed balance

-€66,600.00

Latest filing

19 Dec 2025

How figures are calculated and what is excluded

Signals Pro

Average share-price change 3, 6 and 12 months after each buy

Insider	3 months	6 months	12 months
Insider A	+4.2%	+8.5%	+15.8%
Insider B	+2.6%	+6.1%	+11.4%
Insider C	-1.2%	+3.4%	+7.2%

What happened after each trade?

Go from a single score to the subsequent price performance of each operation.

Price changes after purchases and sales
Compare different holding periods
Inspect the underlying transactions and evidence

Explore Signals Pro

Illustrative example · simulated data, not results for this insider

Recent filings

Recent public filings linked to this insider party
Date	Issuer	Gross reported value	Open
19 Dec 2025	ABIONYX PHARMA	Sell €33,300.00 Buy/sale net: -€33,300.00	Open
19 Dec 2025	ABIONYX PHARMA	Sell €33,300.00 Buy/sale net: -€33,300.00	Open

ABIONYX PHARMA

19 Dec 2025

Sell

€33,300.00

Evidence

Supporting information

ABIONYX PHARMA

Buy/sale net: -€33,300.00

ABIONYX PHARMA

19 Dec 2025

Sell

€33,300.00

Evidence

Supporting information

ABIONYX PHARMA

Buy/sale net: -€33,300.00

Network and companies

1 distinct company in the disclosed relationships. Network coverage is a separate preview.

Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.